- Published on
Pediatrics - Epstein-Barr Virus Infection (Infectious Mononucleosis)
1. BASICS
Description
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus responsible for infectious mononucleosis and several other acute and chronic clinical syndromes.
EBV is also known as human herpesvirus 4 (HHV-4).
It is an enveloped, double-stranded DNA virus belonging to the family Herpesviridae, subfamily Gammaherpesvirinae.
Clinical Spectrum
EBV infection may produce:
- Asymptomatic infection.
- Mild nonspecific febrile illness.
- Infectious mononucleosis.
- Hepatitis.
- Hematological abnormalities.
- Neurological complications.
- Lymphoproliferative disease in susceptible individuals.
Infectious Mononucleosis
The classic syndrome is characterized by:
- Fever.
- Pharyngitis.
- Cervical lymphadenopathy.
- Fatigue.
- Atypical lymphocytosis.
Hepatosplenomegaly may also occur.
Essential Principle
Most EBV infections in immunocompetent children resolve without specific antiviral treatment, but airway obstruction, splenic rupture, severe cytopenias, and neurological complications require urgent recognition.
2. EPIDEMIOLOGY
Worldwide Distribution
EBV infection occurs throughout the world.
Human Reservoir
Humans are the principal natural reservoir.
Seroprevalence
More than 90% of adults worldwide have evidence of previous EBV infection, although prevalence varies by population.
Childhood Infection
Primary infection frequently occurs during childhood.
Adolescent Infection
A second important period of acquisition occurs during adolescence and young adulthood.
Symptomatic Disease
Primary infection in early childhood is often asymptomatic or mild.
Infectious mononucleosis is more likely when primary infection occurs during adolescence.
Clinical Importance
Age at primary infection strongly influences the likelihood of developing the classic mononucleosis syndrome.
3. AGE DISTRIBUTION
Infants
Infection is less common during early infancy, partly because of maternal antibodies and patterns of exposure.
Toddlers and Preschool Children
Primary infection may cause:
- Mild fever.
- Upper respiratory symptoms.
- Cervical lymphadenopathy.
- Nonspecific illness.
School-Age Children
Symptoms may resemble other viral infections.
Adolescents
Classic infectious mononucleosis becomes increasingly common.
Young Adults
Often develop a recognizable syndrome of fever, pharyngitis, lymphadenopathy, and prolonged fatigue.
Clinical Importance
A young child with acute EBV infection may not have the classic findings expected in adolescent infectious mononucleosis.
4. MODES OF TRANSMISSION
Saliva
The principal route of EBV transmission.
Common Exposures
These include:
- Kissing.
- Sharing drinking containers.
- Sharing utensils.
- Contact with saliva-contaminated objects.
Blood Products
Transmission through transfusion is possible but less common.
Organ Transplantation
EBV may be transmitted through transplanted organs.
Other Body Fluids
Transmission through sexual contact and other body-fluid exposures can occur.
Vertical Transmission
Transmission around pregnancy or childbirth is uncommon and is not a major route of typical EBV acquisition.
Clinical Importance
Casual contact generally presents less risk than direct saliva exposure, and routine isolation of otherwise healthy children is unnecessary.
5. INCUBATION PERIOD
General Principles
The incubation period varies with age and the clinical syndrome.
Classic Infectious Mononucleosis
Symptoms typically develop approximately:
Four to six weeks after exposure.
Range
An incubation period of roughly four to seven weeks is often described.
Young Children
The timing of infection may be difficult to establish because symptoms are frequently mild or absent.
Clinical Importance
An exposure history may be unrevealing because infection commonly occurs weeks before symptoms develop.
6. VIRAL SHEDDING
General Principles
EBV is shed intermittently in saliva.
During Primary Infection
Salivary shedding may be substantial.
After Recovery
Viral shedding can continue for months after acute illness.
Lifelong Persistence
Previously infected individuals may intermittently shed EBV despite feeling well.
Transmission Implications
There is no reliable symptom-based point at which an individual can be considered permanently noninfectious.
Clinical Importance
Routine prolonged isolation or exclusion from school until salivary EBV shedding stops is neither practical nor recommended.
7. VIROLOGY
Virus Classification
EBV belongs to the human gammaherpesviruses.
Genetic Material
The viral genome consists of double-stranded DNA.
Viral Envelope
The envelope contains glycoproteins involved in host-cell attachment and entry.
Primary Cellular Targets
These include:
- B lymphocytes.
- Certain epithelial cells.
Viral Persistence
EBV establishes lifelong latency within the B-cell compartment.
Reactivation
Latent virus may periodically reactivate.
Clinical Importance
Lifelong EBV persistence is typical after infection and does not by itself indicate chronic active EBV disease.
8. PATHOPHYSIOLOGY
Initial Infection
EBV enters through exposure to infected saliva.
Oropharyngeal Involvement
The virus infects cells in the oropharyngeal region and establishes infection in B lymphocytes.
B-Cell Activation
Infected B cells undergo activation and proliferation.
Cytotoxic T-Cell Response
The immune system mounts a strong cellular response against infected cells.
Lymphoid Enlargement
Immune activation produces enlargement of:
- Tonsils.
- Lymph nodes.
- Spleen.
Systemic Symptoms
The inflammatory response contributes to:
- Fever.
- Fatigue.
- Malaise.
- Myalgia.
Clinical Importance
Many manifestations of infectious mononucleosis result from the host immune response rather than direct destruction of tissues by the virus.
9. B-LYMPHOCYTE INFECTION
General Principles
EBV infects B lymphocytes through viral attachment and entry mechanisms involving cellular receptors.
CD21
CD21 is an important receptor involved in B-cell entry.
B-Cell Activation
Infection can promote proliferation and altered immune signaling.
Latency
The virus persists within a population of memory B cells.
Immune Surveillance
T-cell-mediated immunity normally controls EBV-infected B cells.
Immunodeficiency
Impaired cellular immune control may allow abnormal proliferation of infected lymphocytes.
Clinical Importance
This interaction between EBV and B-cell immunity helps explain the increased risk of lymphoproliferative complications in immunocompromised patients.
10. CELLULAR IMMUNE RESPONSE
General Principles
Cellular immunity is central to controlling primary EBV infection.
Cytotoxic T Lymphocytes
CD8-positive T lymphocytes expand in response to infected B cells.
Atypical Lymphocytes
Many atypical lymphocytes seen on peripheral blood smears are activated reactive T cells.
Cytokine Production
Inflammatory cytokines contribute to:
- Fever.
- Fatigue.
- Lymph node swelling.
- Generalized malaise.
Immune Control
Effective T-cell responses limit uncontrolled B-cell proliferation.
Clinical Importance
Atypical lymphocytosis reflects immune activation and is not equivalent to circulating malignant lymphocytes.
11. LATENCY AND REACTIVATION
General Principles
Following primary infection, EBV remains latent throughout life.
Site of Latency
Memory B lymphocytes are an important reservoir.
Reactivation
Viral replication may recur intermittently.
Immunocompetent Individuals
Reactivation is commonly asymptomatic.
Immunocompromised Individuals
Reactivation or uncontrolled EBV-associated lymphoproliferation may have greater clinical consequences.
Interpretation of Tests
Detection of EBV DNA or antibodies does not automatically indicate symptomatic active disease.
Clinical Importance
Positive EBV IgG or low-level EBV DNA detection should not be interpreted as proof that EBV is causing a child’s current symptoms.
12. CLINICAL SPECTRUM
Asymptomatic Infection
Common during childhood.
Mild Viral Illness
May cause fever, upper respiratory symptoms, or nonspecific fatigue.
Infectious Mononucleosis
Characterized by the classic systemic and lymphoid manifestations.
Organ-Specific Disease
May include:
- Hepatitis.
- Hemolytic anemia.
- Neurological disease.
- Myocarditis.
Severe Immune Dysregulation
Rarely produces:
- Hemophagocytic lymphohistiocytosis.
- Chronic active EBV disease.
- Severe lymphoproliferative disorders.
Clinical Importance
Clinical severity ranges from minimal symptoms to rare life-threatening complications.
13. INFECTIOUS MONONUCLEOSIS
Description
Infectious mononucleosis is the symptomatic clinical syndrome most frequently associated with primary EBV infection in adolescents and young adults.
Classic Triad
Includes:
- Fever.
- Pharyngitis.
- Cervical lymphadenopathy.
Additional Features
Common findings include:
- Fatigue.
- Malaise.
- Tonsillar enlargement.
- Atypical lymphocytosis.
- Splenomegaly.
- Mild hepatitis.
Clinical Importance
The classic triad is helpful but is not required in every patient.
14. PRODROMAL PHASE
General Principles
A nonspecific prodrome may precede classic symptoms.
Duration
Often several days.
Symptoms
These may include:
- Fatigue.
- Malaise.
- Anorexia.
- Headache.
- Myalgia.
- Low-grade fever.
Adolescents
Fatigue may be particularly prominent.
Young Children
The prodrome may not be recognized.
Clinical Importance
Early EBV infection may resemble many other common viral illnesses.
15. ACUTE SYMPTOMATIC PHASE
Fever
May persist for one to two weeks.
Pharyngitis
Often becomes prominent during the acute illness.
Lymphadenopathy
Cervical lymph nodes enlarge.
Fatigue
May significantly limit school attendance and activity.
Appetite
Reduced appetite is common.
Rash
May occur with or without medication exposure.
Abdominal Symptoms
Some patients have:
- Abdominal discomfort.
- Nausea.
- Reduced intake.
Clinical Importance
The duration and intensity of symptoms vary widely between children.
16. FATIGUE
General Principles
Fatigue is one of the most characteristic and sometimes prolonged manifestations.
Acute Illness
May be severe enough to interfere with daily activities.
Convalescence
Fatigue may continue after fever and pharyngitis resolve.
Duration
Many patients recover within several weeks, although fatigue may persist for months in a minority.
Evaluation
Persistent or progressive fatigue warrants assessment for:
- Anemia.
- Sleep problems.
- Other infections.
- Psychological difficulties.
- Alternative medical conditions.
Clinical Importance
Persistent fatigue alone does not establish ongoing active EBV replication.
17. FEVER
General Principles
Fever commonly accompanies symptomatic EBV infection.
Temperature
May range from low-grade to high fever.
Duration
Frequently persists for several days to two weeks.
Associated Symptoms
These include:
- Sweating.
- Chills.
- Myalgia.
- General malaise.
Persistent Fever
Fever that persists unusually long or recurs with clinical deterioration requires reassessment.
Clinical Importance
Persistent or recurrent fever may indicate a complication, secondary infection, or alternative diagnosis.
18. TONSILLOPHARYNGITIS
General Principles
EBV may produce marked tonsillar and pharyngeal inflammation.
Typical Findings
These include:
- Enlarged tonsils.
- Pharyngeal erythema.
- Tonsillar exudates.
- Painful swallowing.
Exudative Disease
May closely resemble group A streptococcal pharyngitis.
Severe Enlargement
Can cause:
- Dysphagia.
- Drooling.
- Muffled voice.
- Upper airway obstruction.
Clinical Importance
Exudative tonsillitis does not establish bacterial infection; EBV and streptococcal pharyngitis may appear similar.
19. PALATAL PETECHIAE
Description
Small red or purple hemorrhagic spots may appear on the soft palate.
Associated Conditions
Palatal petechiae can occur with:
- EBV infection.
- Group A streptococcal pharyngitis.
- Other infections.
Diagnostic Value
Supportive but nonspecific.
Clinical Importance
Palatal petechiae should be interpreted alongside the overall syndrome rather than used as a standalone diagnostic sign.
20. LYMPHADENOPATHY
General Principles
Lymph node enlargement is a common manifestation.
Typical Distribution
Frequently affects:
- Posterior cervical nodes.
- Anterior cervical nodes.
- Other lymph node chains.
Characteristics
Nodes may be:
- Enlarged.
- Mobile.
- Mildly tender.
- Bilateral.
Generalized Adenopathy
May involve axillary or inguinal regions.
Resolution
Nodes generally decrease in size over subsequent weeks.
Clinical Importance
Posterior cervical lymphadenopathy is particularly suggestive when accompanied by fatigue and exudative pharyngitis.
21. SPLENOMEGALY
General Principles
Splenic enlargement results from lymphoid proliferation and immune activation.
Timing
May become most prominent during the first several weeks of illness.
Physical Examination
The spleen may be palpable below the left costal margin.
Important Limitation
Physical examination is not reliably sensitive for detecting splenic enlargement.
Imaging
Ultrasound may demonstrate enlargement, but normal spleen dimensions vary substantially.
Clinical Importance
Splenomegaly creates a risk of splenic rupture and is a major reason for temporary restrictions on athletic activity.
22. HEPATOMEGALY AND HEPATITIS
General Principles
Mild hepatic inflammation is common during symptomatic EBV infection.
Clinical Features
May include:
- Mild right upper abdominal discomfort.
- Hepatomegaly.
- Nausea.
- Reduced appetite.
Laboratory Findings
Transaminase elevations are frequent.
Jaundice
Clinically apparent jaundice is less common.
Severe Hepatitis
Marked liver injury or acute liver failure is rare.
Clinical Importance
EBV-associated transaminase elevation is usually self-limited, but severe or progressive abnormalities require evaluation for other causes and complications.
23. EXANTHEM AND SKIN FINDINGS
General Principles
EBV infection can produce several skin manifestations.
Maculopapular Rash
May occur spontaneously.
Aminopenicillin-Associated Rash
A diffuse morbilliform eruption may develop after amoxicillin or ampicillin exposure.
Other Findings
Occasional manifestations include:
- Urticarial eruption.
- Petechiae.
- Other nonspecific rashes.
Important Distinction
A rash during EBV infection does not automatically indicate an IgE-mediated penicillin allergy.
Clinical Importance
Medication-associated rashes should be documented carefully, with later allergy assessment when appropriate.
24. PRESENTATION IN YOUNG CHILDREN
General Principles
Primary EBV infection in younger children is frequently mild or asymptomatic.
Potential Symptoms
These include:
- Fever.
- Coryza.
- Pharyngitis.
- Lymphadenopathy.
- Rash.
- Abdominal pain.
Atypical Features
The classic adolescent syndrome may be absent.
Laboratory Interpretation
Heterophile tests are less sensitive in young children.
Clinical Importance
EBV-specific serology is preferred over a heterophile assay when laboratory confirmation is necessary in young children.
25. PRESENTATION IN ADOLESCENTS
General Principles
Adolescents are more likely to experience classic infectious mononucleosis.
Prominent Symptoms
These include:
- Severe fatigue.
- Fever.
- Sore throat.
- Swollen cervical lymph nodes.
- Reduced physical activity tolerance.
School Impact
Illness may interfere with attendance and academic work.
Sports Participation
Athletic restrictions may be necessary because of splenic rupture risk.
Clinical Importance
Counseling should address both symptom recovery and safe return to physical activity.
26. HISTORY
General Principles
History should establish illness duration, typical manifestations, and warning signs.
Symptom Timeline
Ask about:
- Initial fatigue.
- Fever onset.
- Sore throat progression.
- Duration of lymph node swelling.
Oral Intake
Assess drinking and swallowing.
Breathing
Ask about:
- Snoring.
- Noisy breathing.
- Dyspnea.
- Inability to swallow secretions.
Abdominal Pain
Ask specifically about left upper quadrant pain.
Medications
Review antibiotics, particularly aminopenicillins.
Clinical Importance
A focused history helps identify patients needing urgent airway or abdominal assessment.
27. EXPOSURE HISTORY
Saliva Exposure
Ask about relevant close contacts when appropriate.
Household Illness
Other family members may have symptoms.
School and Social Exposure
Transmission may occur in settings involving close contact.
Travel
Usually not necessary to establish typical EBV infection but may inform the differential diagnosis.
Transplantation
Organ transplant history significantly changes the risk assessment.
Immunosuppression
Ask about:
- Chemotherapy.
- Transplant medications.
- Primary immunodeficiency.
- Other immunosuppressive treatment.
Clinical Importance
A recognizable exposure is often absent and is not required to diagnose EBV infection.
28. PHYSICAL EXAMINATION
General Appearance
Assess:
- Hydration.
- Alertness.
- Fatigue.
- Respiratory effort.
Oropharynx
Inspect for:
- Tonsillar enlargement.
- Exudates.
- Palatal petechiae.
- Uvular position.
Neck
Assess cervical lymphadenopathy.
Abdomen
Evaluate for:
- Hepatomegaly.
- Splenomegaly.
- Tenderness.
Skin
Look for rash, petechiae, or jaundice.
Neurological Examination
Indicated when neurological symptoms are present.
Clinical Importance
The examination should identify complications rather than merely confirm the classic pharyngitis syndrome.
29. RED FLAGS
Respiratory Distress
May indicate severe tonsillar or pharyngeal obstruction.
Drooling or Inability to Swallow
May indicate severe airway or swallowing compromise.
Severe Left Upper Quadrant Pain
Raises concern for splenic injury.
Referred Left Shoulder Pain
May occur with diaphragmatic irritation from intra-abdominal bleeding.
Syncope or Hypotension
May indicate hemorrhage or another serious complication.
Confusion or Seizures
May indicate neurological involvement.
Marked Pallor or Jaundice
May indicate hemolytic anemia.
Persistent High Fever With Deterioration
May indicate a secondary infection or severe inflammatory complication.
Clinical Importance
Sudden left upper abdominal pain, collapse, or respiratory distress in a child with infectious mononucleosis requires emergency evaluation.
30. DIFFERENTIAL DIAGNOSIS
Infectious Causes
Consider:
- Group A streptococcal pharyngitis.
- Cytomegalovirus.
- Adenovirus.
- Acute HIV infection.
- Toxoplasmosis.
- Human herpesvirus 6.
- Influenza.
- Other respiratory viral infections.
Bacterial Conditions
Consider:
- Peritonsillar abscess.
- Retropharyngeal abscess.
- Diphtheria in relevant circumstances.
Hematological Disorders
Consider:
- Leukemia.
- Lymphoma.
Systemic Inflammatory Conditions
Selected autoimmune and inflammatory diseases may mimic some features.
Clinical Importance
The combination of fever, lymphadenopathy, and atypical lymphocytes is suggestive but not unique to EBV infection.
31. GROUP A STREPTOCOCCAL PHARYNGITIS
General Principles
Streptococcal tonsillopharyngitis may resemble EBV infection.
Shared Features
These include:
- Fever.
- Sore throat.
- Tonsillar exudate.
- Cervical lymphadenopathy.
Findings Suggesting EBV
These include:
- Prominent fatigue.
- Posterior cervical adenopathy.
- Splenomegaly.
- Generalized lymphadenopathy.
Testing
Rapid antigen testing or throat culture may be indicated when streptococcal infection is clinically plausible.
Coinfection and Carriage
Positive streptococcal testing can occasionally reflect carriage rather than causative infection.
Clinical Importance
Treat confirmed clinically relevant group A streptococcal infection appropriately, but avoid empirical aminopenicillins when EBV is strongly suspected and bacterial infection has not been established.
32. CYTOMEGALOVIRUS MONONUCLEOSIS
General Principles
Cytomegalovirus can produce a heterophile-negative mononucleosis-like syndrome.
Features
Possible findings include:
- Prolonged fever.
- Fatigue.
- Malaise.
- Atypical lymphocytosis.
- Elevated liver enzymes.
Pharyngitis
May be less prominent than in classic EBV mononucleosis.
Diagnosis
CMV-specific serology or molecular testing may be indicated in selected cases.
Clinical Importance
CMV should be considered when the mononucleosis syndrome is convincing but EBV testing does not support recent infection.
33. ACUTE HIV INFECTION
General Principles
Acute HIV infection may resemble infectious mononucleosis.
Potential Features
These include:
- Fever.
- Sore throat.
- Lymphadenopathy.
- Rash.
- Fatigue.
- Mucosal ulcers.
Risk Assessment
Use a confidential, age-appropriate exposure history.
Testing
Appropriate HIV antigen-antibody and nucleic acid testing may be necessary depending on the timing of exposure.
Clinical Importance
Acute HIV should be considered in an adolescent with compatible symptoms and relevant risk, especially when EBV studies are negative.
34. HEMATOLOGICAL MALIGNANCY
General Principles
Leukemia and lymphoma may present with fever, fatigue, and lymphadenopathy.
Concerning Findings
These include:
- Persistent or progressive adenopathy.
- Unexplained bruising.
- Significant cytopenias.
- Bone pain.
- Weight loss.
- Persistent night sweats.
- Unusual organ enlargement.
Laboratory Findings
CBC and blood smear abnormalities may raise suspicion.
Clinical Importance
A prolonged or atypical illness should not automatically be attributed to EBV without reassessing for alternative diagnoses.
35. INITIAL DIAGNOSTIC APPROACH
General Principles
Typical infectious mononucleosis may be diagnosed clinically.
When Testing Is Useful
Consider laboratory confirmation when:
- The diagnosis is uncertain.
- Symptoms are atypical.
- Important alternatives must be excluded.
- Sports participation decisions require clarification.
- Complications are suspected.
- The patient is immunocompromised.
Initial Tests
May include:
- CBC with differential.
- Liver enzymes.
- EBV-specific serology.
Heterophile Testing
May be useful in some adolescents but has important limitations.
Clinical Importance
Laboratory investigations should answer a specific clinical question rather than be ordered routinely for every mild viral illness.
36. COMPLETE BLOOD COUNT
General Principles
CBC abnormalities may support a diagnosis of infectious mononucleosis.
Leukocyte Count
May be normal or elevated.
Lymphocytosis
An increased lymphocyte proportion is common.
Atypical Lymphocytes
Reactive lymphocytes may constitute more than 10% of leukocytes.
Neutropenia
Mild transient neutropenia can occur.
Thrombocytopenia
Mild platelet reduction may be present.
Anemia
Severe anemia is unusual and requires evaluation for hemolysis or another process.
Clinical Importance
Atypical lymphocytosis is supportive but not specific for EBV.
37. ATYPICAL LYMPHOCYTES
Description
Atypical or reactive lymphocytes are activated immune cells with characteristic blood smear appearances.
Morphology
They may demonstrate:
- Enlarged cell size.
- Abundant cytoplasm.
- Irregular cell contours.
- Reactive nuclear changes.
Clinical Context
Commonly associated with EBV but may occur with:
- CMV.
- Toxoplasmosis.
- Other infections.
Important Distinction
Reactive lymphocytes are not equivalent to leukemic blasts.
Clinical Importance
Atypical smear findings that are unusual or accompanied by significant cytopenias may warrant hematopathology review.
38. HETEROPHILE ANTIBODY TESTING
General Principles
The heterophile antibody test, often called the Monospot test, detects nonspecific antibodies associated with infectious mononucleosis.
Potential Use
May support diagnosis in adolescents with a typical presentation.
Limitations
False-negative results are more common:
- Early in illness.
- In children younger than five years.
False Positives
May occur with certain other conditions.
Persistence
Heterophile antibodies can remain detectable after recovery.
Current Diagnostic Preference
EBV-specific serology provides more reliable evidence of the stage of EBV infection.
Clinical Importance
A negative Monospot test does not rule out acute EBV infection, particularly in young children or during the first week of symptoms.
39. EBV-SPECIFIC SEROLOGY
General Principles
EBV serology helps distinguish:
- Susceptibility.
- Primary infection.
- Past infection.
- Selected indeterminate patterns.
Main Markers
These include:
- Viral capsid antigen IgM.
- Viral capsid antigen IgG.
- EBV nuclear antigen IgG.
Additional Markers
Early antigen antibodies may occasionally contribute information.
Interpretation
The combination of markers is more useful than any single result.
Clinical Importance
EBV-specific antibody patterns are generally preferred over heterophile testing when laboratory confirmation is important in pediatric patients.
40. VCA IgM
Description
IgM antibodies against the EBV viral capsid antigen appear early during primary infection.
Timing
Often become detectable near symptom onset.
Duration
Usually disappear within approximately four to six weeks, although variation occurs.
Interpretation
Positive VCA IgM with absent EBNA IgG supports primary EBV infection.
Limitations
False positivity and atypical patterns can occur.
Clinical Importance
VCA IgM should be interpreted together with VCA IgG, EBNA IgG, and the clinical presentation.
41. VCA IgG
Description
Viral capsid antigen IgG antibodies develop during primary infection.
Timing
Usually appear early in the acute illness.
Persistence
Generally remain detectable for life.
Interpretation
VCA IgG alone does not establish current infection.
Past Infection
VCA IgG positivity together with EBNA IgG commonly indicates previous infection.
Clinical Importance
A positive EBV VCA IgG result is not evidence that EBV is responsible for a child’s current illness.
42. EBNA IgG
Description
EBV nuclear antigen IgG develops later after primary infection.
Timing
Typically appears approximately two to four months after symptom onset, depending on the assay.
Persistence
Usually remains positive throughout life.
Acute Infection
EBNA IgG is generally absent during early primary infection.
Past Infection
Positive EBNA IgG with VCA IgG supports remote infection.
Important Limitation
Certain assays may produce atypical or false-positive results.
Clinical Importance
EBNA IgG helps distinguish recent primary infection from previous EBV exposure.
43. SEROLOGICAL PATTERNS
Susceptible Individual
Typical findings:
- VCA IgM negative.
- VCA IgG negative.
- EBNA IgG negative.
Acute Primary Infection
Typical findings:
- VCA IgM positive.
- VCA IgG positive or becoming positive.
- EBNA IgG negative.
Past Infection
Typical findings:
- VCA IgM negative.
- VCA IgG positive.
- EBNA IgG positive.
Indeterminate Patterns
May occur with:
- Early seroconversion.
- Assay variability.
- Persistent IgM.
- Cross-reactive antibodies.
Clinical Importance
Unusual patterns may require repeat or confirmatory testing, but repeated testing is unnecessary when the clinical diagnosis is already clear.
44. EARLY ANTIGEN ANTIBODIES
General Principles
Antibodies against EBV early antigens may develop during active infection.
EA IgG
May appear during the acute phase.
Persistence
Can remain detectable for years in some healthy individuals.
Interpretation
EA IgG positivity alone does not prove active symptomatic EBV disease.
Clinical Role
Usually unnecessary for routine diagnosis of uncomplicated infectious mononucleosis.
Clinical Importance
Early antigen results should not be used in isolation to diagnose chronic EBV-related illness.
45. EBV PCR
General Principles
Molecular testing detects EBV DNA in blood or other specimens.
Routine Mononucleosis
PCR is not usually necessary to confirm uncomplicated primary infection.
Important Uses
Include:
- Immunocompromised patients.
- Transplant recipients.
- Suspected posttransplant lymphoproliferative disorder.
- Selected severe or atypical disease.
Interpretation
A positive PCR may reflect:
- Active viral replication.
- EBV-infected circulating cells.
- Other EBV-associated processes.
Viral Load
Serial quantitative testing may be useful in selected immunocompromised patients.
Clinical Importance
A detectable EBV viral load does not by itself establish EBV as the cause of fever, fatigue, or another nonspecific symptom.
46. LIVER FUNCTION TESTS
General Principles
Mild hepatitis commonly accompanies symptomatic EBV infection.
Typical Findings
These include elevated:
- Alanine aminotransferase.
- Aspartate aminotransferase.
Additional Abnormalities
Occasionally:
- Elevated bilirubin.
- Increased alkaline phosphatase.
- Elevated gamma-glutamyl transferase.
Severe Disease
Marked enzyme elevation, impaired coagulation, or jaundice warrants additional evaluation.
Clinical Importance
Routine serial liver testing is not necessary in every mild case, but significant abnormalities should be followed until improvement.
47. HEMATOLOGICAL INVESTIGATIONS
General Principles
Additional testing is indicated when clinically important cytopenias or hemolysis are suspected.
Hemolysis Evaluation
May include:
- Hemoglobin.
- Reticulocyte count.
- Bilirubin.
- Lactate dehydrogenase.
- Haptoglobin.
- Direct antiglobulin test.
Severe Thrombocytopenia
Evaluate platelet count and bleeding risk.
Neutropenia
Assess severity and infection risk.
HLH Evaluation
Consider ferritin, triglycerides, fibrinogen, and other specialized investigations when the clinical presentation is concerning.
Clinical Importance
Severe cytopenias are not typical uncomplicated mononucleosis and require prompt assessment.
48. ABDOMINAL ULTRASOUND
General Principles
Ultrasound can evaluate splenic size and certain abdominal complications.
Potential Indications
These include:
- Suspected splenic injury.
- Unexplained abdominal symptoms.
- Selected uncertain examinations.
Limitations
Normal spleen dimensions vary with:
- Age.
- Height.
- Body habitus.
- Individual baseline size.
Return to Sports
Routine ultrasound is not recommended solely to determine whether an otherwise recovering athlete may return to activity.
Clinical Importance
Ultrasound findings should not replace clinical recovery and an individualized return-to-sport assessment.
49. TREATMENT PRINCIPLES
General Principles
Treatment of uncomplicated infectious mononucleosis is supportive.
Main Objectives
These include:
- Maintain hydration.
- Relieve pain and fever.
- Support adequate nutrition.
- Allow symptom-guided rest.
- Identify complications.
- Reduce splenic injury risk.
Antiviral Medication
Not routinely recommended.
Antibiotics
Not indicated unless a separate bacterial infection is present.
Corticosteroids
Not routinely indicated.
Clinical Importance
Most immunocompetent children recover without disease-specific pharmacological treatment.
50. HYDRATION
General Principles
Adequate fluid intake is important, especially with painful swallowing.
Oral Hydration
Encourage frequent small drinks.
Suitable Fluids
These may include:
- Water.
- Oral rehydration solution.
- Other tolerated beverages.
Soft Foods
May be easier to swallow.
Dehydration Signs
These include:
- Reduced urination.
- Dry mouth.
- Dizziness.
- Lethargy.
- Poor tear production.
Intravenous Fluids
May be needed when oral intake is inadequate.
Clinical Importance
Dehydration from severe pharyngitis is an important potentially preventable reason for hospitalization.
51. ACETAMINOPHEN
General Principles
Acetaminophen may reduce fever and throat pain.
Pediatric Dose
10–15 mg/kg per dose orally every four to six hours as needed.
Maximum Dose
Follow local pediatric maximum daily dosing and avoid duplicate acetaminophen-containing products.
Liver Precautions
Use particular caution with:
- Significant hepatitis.
- Liver dysfunction.
- Dehydration.
- Other hepatotoxic medication exposure.
Clinical Importance
Appropriate symptom relief can improve oral intake, but excessive acetaminophen dosing should be avoided.
52. IBUPROFEN
General Principles
Ibuprofen may reduce fever and throat discomfort.
Pediatric Dose
For eligible children aged six months or older:
5–10 mg/kg per dose orally every six to eight hours as needed.
Typical Maximum
Do not exceed the age- and weight-appropriate daily maximum, commonly 40 mg/kg/day.
Contraindications and Precautions
Avoid or use caution with:
- Significant dehydration.
- Acute kidney injury.
- Gastrointestinal bleeding.
- NSAID hypersensitivity.
Thrombocytopenia
Avoid NSAIDs when clinically important bleeding risk is present.
Clinical Importance
Analgesics should be chosen according to the child’s hydration, kidney function, liver status, and bleeding risk.
53. REST AND ACTIVITY
General Principles
Rest is appropriate during the symptomatic phase.
Sleep
Encourage adequate sleep.
Daily Activities
Resume light activities as tolerated once systemic symptoms improve.
Prolonged Bed Rest
Strict bed rest is not necessary throughout recovery.
Athletic Activity
Requires separate consideration because of splenic rupture risk.
Fatigue
Activity should be increased gradually rather than abruptly.
Clinical Importance
Symptom-guided recovery is appropriate for normal daily activities, but vigorous exercise and contact sports require additional restrictions.
54. SORE THROAT MANAGEMENT
Supportive Measures
These may include:
- Oral fluids.
- Cold beverages.
- Soft foods.
- Age-appropriate analgesics.
- Salt-water gargles in children old enough to perform them safely.
Severe Symptoms
Assess for:
- Dehydration.
- Airway obstruction.
- Peritonsillar abscess.
- Secondary bacterial infection.
Avoid
Do not use antibiotics solely because the tonsils have exudates.
Clinical Importance
The ability to maintain oral intake is an important measure of illness severity.
55. ANTIBIOTIC USE
General Principles
Antibiotics do not treat EBV infection.
Indications
Use only when a separate bacterial infection is established or strongly suspected.
Group A Streptococcus
Treat according to appropriate testing and local guidelines.
Aminopenicillins
Amoxicillin and ampicillin are associated with an increased frequency of rash during acute EBV infection.
Important Distinction
An aminopenicillin-associated rash does not invariably indicate a persistent penicillin allergy.
Clinical Importance
Avoid unnecessary antibiotics in EBV mononucleosis, particularly when exudative pharyngitis has not been confirmed as bacterial.
56. AMINOPENICILLIN-ASSOCIATED RASH
General Principles
A morbilliform rash may occur during EBV infection after aminopenicillin exposure.
Clinical Appearance
Often characterized by:
- Diffuse pink or red macules.
- Papules.
- Symmetric distribution.
- Variable itching.
Timing
Frequently develops several days after the antibiotic is started.
Mechanism
May involve transient immune alterations, although true drug hypersensitivity can also coexist.
Management
Reassess whether the antibiotic is necessary.
Allergy Assessment
Consider formal evaluation if the history suggests immediate hypersensitivity or the future penicillin allergy label is uncertain.
Clinical Importance
Do not permanently label every child with an EBV-associated amoxicillin rash as penicillin-allergic without reviewing the reaction.
57. CORTICOSTEROIDS
General Principles
Systemic corticosteroids are not recommended for routine uncomplicated infectious mononucleosis.
Potential Indications
May be considered for serious complications such as:
- Impending upper airway obstruction.
- Severe immune-mediated hemolytic anemia.
- Severe immune thrombocytopenia.
- Selected life-threatening inflammatory complications.
Treatment Selection
Depends on:
- Severity.
- Clinical condition.
- Organ involvement.
- Specialist assessment.
Dosing
There is no single standard corticosteroid regimen appropriate for all EBV complications.
Important Limitation
Routine corticosteroids do not reliably shorten uncomplicated illness or prevent prolonged fatigue.
Clinical Importance
Corticosteroids should be reserved for selected serious complications, not prescribed merely for severe-looking tonsillar exudates or routine sore throat.
58. ANTIVIRAL THERAPY
General Principles
Acyclovir and related antivirals inhibit aspects of lytic EBV replication.
Clinical Evidence
They may reduce viral shedding but have not shown consistent meaningful improvement in uncomplicated infectious mononucleosis outcomes.
Routine Use
Not recommended.
Severe EBV Disease
Specialist-directed antiviral treatment may occasionally be considered in unusual circumstances.
Transplant Recipients
Management is different and focuses on immune control and EBV-associated complications.
Clinical Importance
Routine acyclovir or valacyclovir should not be prescribed for uncomplicated EBV mononucleosis.
59. AIRWAY OBSTRUCTION
General Principles
Marked tonsillar and adenoidal enlargement may narrow the upper airway.
Symptoms
These include:
- Difficulty breathing.
- Noisy breathing.
- Severe snoring.
- Drooling.
- Inability to swallow.
- Muffled voice.
Initial Management
Requires urgent airway assessment.
Treatment
May include:
- Hospital admission.
- ENT consultation.
- Carefully selected systemic corticosteroids.
- Airway support.
Severe Cases
Intubation may rarely be required.
Clinical Importance
Progressive respiratory difficulty in EBV mononucleosis is an emergency and should not be managed solely with outpatient steroids.
60. SPLENIC RUPTURE
General Principles
Splenic rupture is an uncommon but potentially fatal complication.
Mechanism
Splenic enlargement and altered tissue integrity increase susceptibility to injury.
Traumatic Rupture
May occur after abdominal impact or athletic activity.
Atraumatic Rupture
Can occur without a recognized injury.
Symptoms
These include:
- Sudden left upper quadrant pain.
- Left shoulder pain.
- Dizziness.
- Syncope.
- Pallor.
- Hypotension.
Emergency Management
Requires immediate hospital evaluation and resuscitation.
Clinical Importance
Sudden abdominal pain or collapse during or after infectious mononucleosis must raise concern for splenic rupture, even without a history of trauma.
61. RETURN TO SPORTS
General Principles
Physical activity restrictions aim to reduce the risk of splenic injury.
Initial Restriction
Current sports medicine guidance commonly recommends avoiding athletic activity for at least:
Three weeks from symptom onset.
Early Return
After approximately three weeks, gradual light noncontact activity may be considered if the athlete is:
- Afebrile.
- Clinically well.
- Recovering appropriately.
- Free of concerning abdominal symptoms.
Contact Sports
Require additional individualized assessment because of potential abdominal trauma.
Heavy Lifting
Should also be considered in activity restrictions.
Clinical Importance
A blanket clearance at exactly 21 days is inappropriate for children who remain symptomatic or participate in activities with substantial abdominal impact risk.
62. SPORTS CLEARANCE AND SPLENIC IMAGING
General Principles
Return-to-play decisions should consider the child’s clinical recovery and sport.
Clinical Factors
These include:
- Date of symptom onset.
- Resolution of systemic illness.
- Abdominal symptoms.
- Sport-specific injury risk.
- Individual circumstances.
Physical Examination
Cannot reliably determine whether the spleen has returned to normal size.
Ultrasound
Routine single-point ultrasound is not recommended solely to accelerate clearance.
Contact Sports
Shared decision-making is necessary and may involve a longer restriction period.
Clinical Importance
No single ultrasound measurement reliably establishes that splenic rupture risk has returned to zero.
63. HEMOLYTIC ANEMIA
General Principles
EBV may trigger autoimmune hemolytic anemia.
Mechanisms
Cold-reactive antibodies are associated with some cases.
Clinical Features
These include:
- Pallor.
- Fatigue.
- Jaundice.
- Dark urine.
- Tachycardia.
Investigations
May include:
- CBC.
- Reticulocyte count.
- Bilirubin.
- LDH.
- Haptoglobin.
- Direct antiglobulin test.
Treatment
Depends on severity and mechanism.
Clinical Importance
Severe anemia, rapidly progressive jaundice, or hemodynamic instability requires urgent assessment.
64. THROMBOCYTOPENIA
General Principles
Mild thrombocytopenia is relatively common during acute EBV infection.
Severe Disease
Marked platelet reduction is much less common.
Clinical Features
Possible findings include:
- Petechiae.
- Bruising.
- Epistaxis.
- Mucosal bleeding.
Investigations
CBC and blood smear are central.
Treatment
Mild cases often require observation.
Severe immune-mediated thrombocytopenia may require specialist-directed treatment.
Clinical Importance
Significant bleeding or very low platelet counts require prompt hematology involvement.
65. NEUTROPENIA AND BONE MARROW SUPPRESSION
General Principles
Transient neutropenia may occur during EBV infection.
Severity
Most cases are mild.
Severe Neutropenia
May increase susceptibility to bacterial infection.
Rare Complications
EBV has been associated with severe marrow suppression and aplastic anemia.
Assessment
Investigate persistent or severe cytopenias.
Clinical Importance
Prolonged pancytopenia should not be attributed automatically to uncomplicated EBV infection.
66. EBV-ASSOCIATED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Description
Hemophagocytic lymphohistiocytosis (HLH) is a potentially life-threatening syndrome of excessive immune activation.
EBV Association
EBV is an important infectious trigger of secondary HLH.
Clinical Features
These may include:
- Persistent high fever.
- Hepatosplenomegaly.
- Cytopenias.
- Liver dysfunction.
- Coagulopathy.
- Neurological symptoms.
Laboratory Clues
May include:
- Very high ferritin.
- Elevated triglycerides.
- Low fibrinogen.
- Cytopenias.
Management
Requires urgent specialist treatment and may include immune-directed therapy.
Clinical Importance
Persistent fever with worsening cytopenias, hepatosplenomegaly, and organ dysfunction should prompt urgent evaluation for HLH.
67. NEUROLOGICAL COMPLICATIONS
General Principles
Neurological complications are uncommon but may be serious.
Potential Syndromes
These include:
- Aseptic meningitis.
- Encephalitis.
- Cerebellitis.
- Guillain-Barré syndrome.
- Facial nerve palsy.
- Transverse myelitis.
- Optic neuritis.
Clinical Features
May include:
- Severe headache.
- Altered consciousness.
- Seizures.
- Ataxia.
- Weakness.
- Cranial nerve abnormalities.
Evaluation
May require:
- Neuroimaging.
- Lumbar puncture.
- EEG.
- Specialist laboratory testing.
Clinical Importance
Neurological symptoms should be investigated independently rather than assumed to be benign manifestations of mononucleosis.
68. HEPATIC COMPLICATIONS
General Principles
Most EBV-associated hepatitis is mild and self-limited.
Typical Findings
Include moderate transaminase elevation.
Cholestatic Hepatitis
May cause:
- Jaundice.
- Dark urine.
- Pale stools.
- Pruritus.
Severe Hepatitis
Rarely causes significant synthetic dysfunction.
Acute Liver Failure
Very uncommon but life-threatening.
Monitoring
Assess coagulation and liver function when significant hepatic injury is suspected.
Clinical Importance
Jaundice, encephalopathy, abnormal coagulation, or rapidly rising liver enzymes require urgent specialist assessment.
69. CARDIAC COMPLICATIONS
General Principles
Cardiac involvement is rare.
Myocarditis
May cause:
- Chest pain.
- Tachycardia.
- Dyspnea.
- Reduced cardiac function.
Pericarditis
May present with chest pain and pericardial inflammation.
Arrhythmias
Can occur with myocardial involvement.
Investigations
May include:
- ECG.
- Troponin.
- Echocardiography.
- Cardiac MRI in selected cases.
Clinical Importance
Chest pain, syncope, unexplained tachycardia, or signs of heart failure require prompt assessment.
70. EBV IN IMMUNOCOMPROMISED CHILDREN
General Principles
Impaired immune surveillance increases the risk of severe or persistent EBV-associated disease.
High-Risk Groups
These include:
- Solid organ transplant recipients.
- Hematopoietic stem cell transplant recipients.
- Children receiving significant immunosuppression.
- Selected primary immunodeficiency disorders.
Potential Complications
These include:
- High EBV viral loads.
- Lymphoproliferative disease.
- Severe organ involvement.
- Uncontrolled B-cell proliferation.
Monitoring
Some patients require quantitative EBV PCR surveillance.
Clinical Importance
EBV infection in a transplant recipient requires a different diagnostic and treatment approach from uncomplicated mononucleosis in an immunocompetent child.
71. POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Description
Posttransplant lymphoproliferative disorder (PTLD) encompasses abnormal lymphoid proliferation developing in the setting of transplant-associated immunosuppression.
EBV Association
Many pediatric PTLD cases are EBV-associated.
Risk Factors
These include:
- EBV-seronegative recipient status before transplant.
- Primary EBV infection after transplantation.
- Intensity of immunosuppression.
- Type of transplant.
Clinical Features
May include:
- Fever.
- Lymphadenopathy.
- Tonsillar enlargement.
- Organ masses.
- Unexplained graft dysfunction.
Diagnosis
Requires appropriate imaging and often tissue biopsy.
Clinical Importance
EBV viral load supports monitoring but does not independently diagnose PTLD.
72. PTLD TREATMENT
General Principles
Treatment is determined by transplant and oncology specialists.
Reduction of Immunosuppression
Often an important initial strategy when feasible.
Rituximab
May be appropriate for selected CD20-positive B-cell PTLD.
Chemotherapy
Required for certain aggressive or refractory forms.
Surgical Treatment
May occasionally be appropriate for localized disease or complications.
Monitoring
Includes:
- EBV viral load trends.
- Disease imaging.
- Graft function.
- Treatment toxicity.
Clinical Importance
Treatment must balance control of lymphoproliferative disease against the risk of transplanted organ rejection.
73. CHRONIC ACTIVE EBV DISEASE
Description
Chronic active EBV disease is a rare, serious EBV-associated lymphoproliferative or inflammatory disorder involving persistently infected T or NK cells in many recognized cases.
Clinical Features
May include:
- Persistent or recurrent fever.
- Hepatosplenomegaly.
- Lymphadenopathy.
- Hepatitis.
- Cytopenias.
- Organ dysfunction.
Diagnostic Requirements
Require more than prolonged fatigue or positive EBV antibodies.
Assessment
May involve:
- EBV DNA quantification.
- Identification of infected cell populations.
- Tissue studies.
- Specialist evaluation.
Treatment
Severe disease may require hematopoietic stem cell transplantation.
Clinical Importance
Chronic active EBV disease is distinct from prolonged fatigue after ordinary infectious mononucleosis.
74. X-LINKED LYMPHOPROLIFERATIVE DISEASE
General Principles
Certain inherited immune disorders are associated with severe EBV susceptibility.
X-Linked Lymphoproliferative Disease
May cause unusually severe reactions to EBV.
Potential Manifestations
These include:
- HLH.
- Severe hepatitis.
- Lymphoma.
- Dysgammaglobulinemia.
- Fulminant infection.
Genetic Mechanisms
Defects in specific immune regulatory pathways may impair EBV control.
Family History
Ask about:
- Male relatives with severe EBV disease.
- Unexplained early deaths.
- Familial immunodeficiency.
Clinical Importance
Severe EBV disease in a young boy may warrant assessment for an underlying primary immune disorder.
75. EBV-ASSOCIATED MALIGNANCIES
General Principles
EBV is associated with several malignancies, but the overwhelming majority of infected children never develop cancer.
Important Associations
These include:
- Burkitt lymphoma.
- Hodgkin lymphoma.
- Certain non-Hodgkin lymphomas.
- Nasopharyngeal carcinoma.
- Posttransplant lymphoproliferative disorders.
Geographic Factors
Associations vary by region and cofactors.
Immune Status
Immunosuppression increases risk for some EBV-associated lymphoid malignancies.
Clinical Importance
Past EBV infection is extremely common and does not mean that a child will develop an EBV-associated cancer.
76. HOSPITAL ADMISSION
General Principles
Most immunocompetent children with infectious mononucleosis can be treated as outpatients.
Admission Indications
These include:
- Upper airway obstruction.
- Significant dehydration.
- Inability to swallow fluids.
- Suspected splenic rupture.
- Severe anemia.
- Significant thrombocytopenia with bleeding.
- Neurological complications.
- Severe hepatitis.
- Suspected HLH.
Immunocompromised Patients
May require admission for specialized evaluation.
Clinical Importance
Hospitalization is driven by complications and physiological instability, not a positive EBV test alone.
77. PEDIATRIC INTENSIVE CARE
General Principles
PICU admission is necessary for selected severe complications.
Indications
These include:
- Severe airway obstruction.
- Respiratory failure.
- Hemorrhagic shock.
- Severe encephalitis.
- Fulminant HLH.
- Severe myocarditis.
- Multiorgan dysfunction.
Monitoring
May include:
- Continuous ECG.
- Respiratory monitoring.
- Hemodynamic monitoring.
- Serial blood testing.
Organ Support
May require:
- Mechanical ventilation.
- Vasoactive medications.
- Blood products.
- Specialized immune-directed treatment.
Clinical Importance
Rapid escalation is essential when an ordinarily benign EBV illness develops a life-threatening complication.
78. NURSING CONSIDERATIONS
General Principles
Nursing care focuses on hydration, comfort, recognition of complications, and education.
Monitoring
Assess:
- Temperature.
- Oral intake.
- Urine output.
- Pain.
- Respiratory status.
- Fatigue.
Throat Symptoms
Observe for increasing tonsillar swelling or swallowing difficulty.
Abdominal Symptoms
Report sudden left upper quadrant pain.
Medication Safety
Ensure age-appropriate antipyretic dosing.
Emotional Support
Help the child and family understand the expected recovery course.
Clinical Importance
Prompt identification of worsening airway, abdominal, or neurological symptoms can prevent serious adverse outcomes.
79. INFECTION CONTROL AND SCHOOL ATTENDANCE
General Principles
Routine standard precautions are appropriate for most hospitalized patients.
Additional Precautions
May be required when another transmissible infection is suspected.
School Attendance
Children may return when they:
- Are afebrile.
- Feel sufficiently well.
- Can participate in ordinary activities.
- Meet school illness policies.
Viral Shedding
Prolonged shedding is not a reason for months of school exclusion.
Activity Restrictions
School attendance and sports clearance are separate decisions.
Clinical Importance
A child may be well enough to attend school before being medically ready to resume contact sports.
80. FOLLOW-UP AND MONITORING
General Principles
Follow-up should be individualized according to symptom duration and complications.
Typical Cases
Reassessment is appropriate when symptoms do not improve as expected.
Persistent Fatigue
Review:
- Functional recovery.
- Sleep.
- Hydration.
- Nutrition.
- Alternative diagnoses.
Abnormal Liver Tests
Repeat when initially significant or clinically indicated.
Cytopenias
Monitor until improvement when clinically important abnormalities were present.
Splenic Symptoms
Investigate new abdominal pain urgently.
Immunocompromised Patients
May require prolonged specialist surveillance.
Clinical Importance
Follow-up should emphasize functional recovery and detection of complications rather than repeated EBV antibody testing.
81. PATIENT AND FAMILY EDUCATION
General Principles
Families should understand that infectious mononucleosis usually resolves without specific antiviral treatment.
Key Messages
Explain that:
- EBV is common.
- Many children have mild disease.
- Fatigue may persist beyond the sore throat.
- Antibiotics do not treat EBV.
- Salivary transmission is possible.
- Splenic injury is rare but serious.
Hydration
Encourage adequate fluid intake.
Activity
Avoid strenuous exercise and contact sports during the high-risk recovery period.
Warning Symptoms
Seek emergency care for:
- Breathing difficulty.
- Inability to drink.
- Sudden severe abdominal pain.
- Syncope.
- Confusion.
- Significant bleeding.
Clinical Importance
Education should balance reassurance with clear instructions for recognizing dangerous complications.
82. PREVENTION
General Principles
No EBV vaccine is currently available for routine clinical use.
Saliva Exposure
Avoid sharing:
- Toothbrushes.
- Drinks.
- Utensils contaminated with saliva.
Kissing
Avoid direct saliva contact with symptomatic individuals when feasible.
Hand Hygiene
Encourage routine hygiene.
Contact Restrictions
Prolonged isolation is not practical because EBV shedding can continue after recovery.
Immunocompromised Patients
Require individualized exposure and infection-prevention counseling.
Clinical Importance
Prevention focuses on reducing direct saliva exposure, although complete prevention of this common lifelong infection is difficult.
83. SPECIAL CONSIDERATIONS FOR TRANSPLANT RECIPIENTS
General Principles
Pretransplant EBV serostatus is important in risk assessment.
Seronegative Recipients
May be at higher risk of PTLD following primary EBV infection after transplantation.
Viral Load Monitoring
Programs may use serial quantitative EBV PCR testing in selected high-risk recipients.
Interpretation
Viral load thresholds vary between laboratories and transplant protocols.
Treatment Decisions
May involve:
- Adjustment of immunosuppression.
- Further imaging.
- Tissue biopsy.
- Targeted treatment.
Clinical Importance
EBV management in transplantation requires established center-specific protocols rather than general mononucleosis management.
84. PROGNOSIS
General Outlook
The prognosis of primary EBV infection in immunocompetent children is excellent.
Asymptomatic Infection
Most children infected at a young age experience minimal or no recognizable symptoms.
Classic Mononucleosis
Acute symptoms generally improve over:
Two to four weeks.
Prolonged Fatigue
Fatigue may continue for several additional weeks or occasionally months.
Lymphadenopathy
Enlarged lymph nodes may resolve gradually.
Splenomegaly
Splenic enlargement may persist beyond the resolution of fever and pharyngitis.
Hepatitis
Mild liver enzyme abnormalities usually resolve spontaneously.
Recurrent Symptoms
Prolonged fatigue or other nonspecific symptoms should not automatically be attributed to active EBV infection.
Lifelong Latency
EBV remains latent after recovery.
Immunity
Primary infection generally produces long-lasting immune control and makes another primary mononucleosis episode unlikely.
Severe Complications
Prognosis depends on the affected organ and speed of treatment.
Splenic Rupture
Outcome is often favorable with prompt diagnosis and management but can be fatal if hemorrhage is not recognized.
Airway Obstruction
Usually improves with appropriate supportive or specialized treatment.
HLH
May cause significant morbidity and mortality.
Immunodeficiency
Children with impaired EBV-specific immune control have a greater risk of severe or persistent disease.
Transplant Recipients
Prognosis depends on the presence and extent of EBV-associated lymphoproliferative disease.
EBV-Associated Malignancy
Outcome depends on the specific cancer and its treatment.
Favorable Prognostic Factors
These include:
- Immunocompetent status.
- Adequate hydration.
- Absence of organ-threatening complications.
- Gradual clinical improvement.
- Appropriate activity restriction.
Poor Prognostic Factors
These include:
- Severe immunodeficiency.
- HLH.
- Severe airway compromise.
- Splenic hemorrhage.
- Severe neurological disease.
- Major organ failure.
Clinical Importance
Most children recover completely, and persistent EBV antibodies after recovery are normal rather than evidence of ongoing disease.
85. COMPLICATIONS
Dehydration
Severe sore throat and reduced intake may cause fluid depletion.
Reduced Oral Intake
Painful swallowing may prevent adequate drinking and eating.
Weight Loss
Acute illness may cause temporary weight loss.
Malnutrition
Severe prolonged feeding impairment may compromise nutritional status.
Electrolyte Disturbances
Dehydration or severe illness may alter electrolyte concentrations.
Persistent Pharyngitis
Throat pain and inflammation may continue beyond the initial febrile period.
Severe Tonsillar Hypertrophy
Marked enlargement may cause obstructive symptoms.
Dysphagia
Swallowing may become difficult because of pharyngeal inflammation.
Odynophagia
Severe pain may occur during swallowing.
Muffled Voice
Extensive tonsillar swelling may alter voice quality.
Snoring
Upper airway narrowing may cause noisy sleep breathing.
Sleep-Disordered Breathing
Tonsillar enlargement may interfere with ventilation during sleep.
Upper Airway Obstruction
Severe lymphoid hyperplasia may compromise the upper airway.
Respiratory Distress
Significant obstruction may increase respiratory effort.
Hypoxemia
Severe obstruction may impair oxygenation.
Respiratory Failure
Rarely, airway compromise may require mechanical ventilation.
Emergency Airway Intervention
Severe obstruction may necessitate intubation.
Peritonsillar Abscess
Secondary bacterial infection may produce a localized collection.
Retropharyngeal Infection
Rarely, deep neck infection may coexist or develop.
Suppurative Cervical Lymphadenitis
Secondary infection may cause painful inflamed lymph nodes.
Bacterial Sinusitis
Secondary bacterial infection of the sinuses may occur.
Otitis Media
Middle ear infection may develop during a respiratory illness.
Mastoiditis
Rarely, infection may involve the mastoid structures.
Sialadenitis
Salivary gland inflammation may occur.
Persistent Cervical Lymphadenopathy
Nodes may remain enlarged for several weeks.
Generalized Lymphadenopathy
Multiple lymph node groups may become enlarged.
Splenomegaly
Lymphoid proliferation may enlarge the spleen.
Splenic Pain
Splenic capsule stretching may cause left upper abdominal discomfort.
Splenic Infarction
Rarely, compromised splenic blood flow may cause infarction.
Splenic Hematoma
Injury may produce localized splenic bleeding.
Splenic Rupture
The enlarged spleen may tear spontaneously or after trauma.
Intra-Abdominal Hemorrhage
Splenic rupture may cause major internal bleeding.
Hemorrhagic Shock
Severe bleeding may impair circulation.
Syncope
Significant blood loss may cause fainting.
Referred Left Shoulder Pain
Blood or inflammation beneath the diaphragm may produce shoulder pain.
Emergency Splenic Intervention
Selected patients may require embolization or surgery.
Splenectomy
Rarely necessary for uncontrolled hemorrhage.
Postsplenectomy Infection Risk
Children who lose the spleen require long-term protection against invasive encapsulated bacterial infections.
Hepatitis
Transient liver inflammation is common.
Transaminase Elevation
Serum ALT and AST may increase.
Hepatomegaly
The liver may become enlarged.
Cholestatic Hepatitis
Bile flow abnormalities may produce jaundice.
Hyperbilirubinemia
Bilirubin concentrations may increase during hepatitis or hemolysis.
Jaundice
Yellow discoloration may occur in more pronounced disease.
Pruritus
Cholestasis may cause itching.
Coagulopathy
Severe liver injury may impair clotting factor production.
Acute Liver Failure
Rarely, severe hepatitis may cause life-threatening hepatic dysfunction.
Autoimmune Hemolytic Anemia
EBV may trigger immune-mediated red blood cell destruction.
Cold Agglutinin-Associated Hemolysis
Cold-reactive antibodies may contribute to hemolysis.
Severe Anemia
Marked hemolysis or marrow suppression may reduce hemoglobin substantially.
Hemoglobinuria
Intravascular hemolysis may cause dark urine.
Thrombocytopenia
Platelet counts may decrease.
Severe Immune Thrombocytopenia
Occasionally, immune-mediated platelet destruction causes severe thrombocytopenia.
Petechiae
Low platelet counts may produce small skin hemorrhages.
Purpura
Bleeding into skin may produce larger purple lesions.
Mucosal Bleeding
Severe thrombocytopenia may cause epistaxis or gum bleeding.
Neutropenia
Reduced neutrophil counts may occur.
Agranulocytosis
Profound neutropenia is rare.
Pancytopenia
Multiple blood cell lines may be reduced.
Aplastic Anemia
Severe bone marrow suppression is an uncommon complication.
Hemophagocytic Lymphohistiocytosis
EBV may trigger severe systemic immune activation.
Hyperferritinemia
HLH may cause markedly elevated ferritin.
Hypofibrinogenemia
HLH-associated coagulopathy may lower fibrinogen.
Disseminated Intravascular Coagulation
Severe inflammatory disease may cause systemic coagulation abnormalities.
Multiorgan Dysfunction
HLH or severe systemic illness may impair several organs.
Aseptic Meningitis
Inflammation of the meninges may occur.
Encephalitis
EBV-associated brain inflammation may cause altered mental status or seizures.
Meningoencephalitis
Combined meningeal and brain involvement may develop.
Cerebellitis
Cerebellar inflammation may cause ataxia and coordination difficulties.
Acute Ataxia
Children may develop abnormal gait or balance.
Seizures
Neurological involvement may provoke convulsions.
Status Epilepticus
Severe neurological inflammation may cause prolonged seizures.
Encephalopathy
Systemic inflammation or direct neurological involvement may impair cognition and consciousness.
Facial Nerve Palsy
Peripheral facial weakness may occur.
Guillain-Barré Syndrome
Postinfectious immune neuropathy may cause progressive weakness.
Peripheral Neuritis
Inflammation may involve peripheral nerves.
Optic Neuritis
Rarely, optic nerve inflammation may impair vision.
Transverse Myelitis
Spinal cord inflammation may cause weakness and sensory or bladder abnormalities.
Persistent Neurological Deficits
Severe neurological disease may leave lasting functional impairment.
Myocarditis
Inflammation of the heart muscle may impair cardiac function.
Pericarditis
Inflammation may affect the pericardium.
Pericardial Effusion
Fluid may accumulate around the heart.
Cardiac Arrhythmias
Myocardial involvement may disturb heart rhythm.
Heart Failure
Severe myocarditis may reduce cardiac output.
Pancreatitis
Rarely, pancreatic inflammation may cause severe abdominal pain and vomiting.
Mesenteric Adenitis
Abdominal lymph node inflammation may cause pain.
Orchitis
Testicular inflammation is a rare complication.
Genital Ulceration
Acute non-sexually acquired genital ulcers may be associated with EBV infection.
Rash
A maculopapular eruption may occur during primary infection.
Aminopenicillin-Associated Rash
Amoxicillin or ampicillin exposure may precipitate a morbilliform eruption.
Incorrect Penicillin Allergy Label
A non-IgE-mediated eruption may lead to unnecessary lifelong avoidance of beta-lactam antibiotics.
Urticaria
Hives may occur with infection or medication exposure.
Persistent Fatigue
Fatigue may continue for weeks or months.
Postinfectious Fatigue Syndrome
A subset of patients develops prolonged functional impairment after acute illness.
Sleep Disturbance
Illness and fatigue may disrupt normal sleep patterns.
Reduced Exercise Tolerance
Physical stamina may remain limited during recovery.
School Absenteeism
Acute illness or persistent fatigue may interfere with education.
Academic Difficulties
Reduced attention or energy may affect schoolwork temporarily.
Social Withdrawal
Children may reduce participation in social activities.
Anxiety
Prolonged illness or fear of complications may cause anxiety.
Depressive Symptoms
Extended functional limitation may contribute to low mood.
Family Stress
Caregivers may experience practical and emotional burdens.
Prolonged Athletic Restriction
Sports participation may be delayed while the child recovers.
Anxiety About Splenic Injury
Athletes may be concerned about returning to training.
Invasive EBV-Associated Lymphoproliferation
Failure of immune control may permit abnormal proliferation of infected lymphocytes.
Posttransplant Lymphoproliferative Disorder
Transplant recipients may develop EBV-associated lymphoid disease.
Chronic Active EBV Disease
Rare persistent EBV-positive T- or NK-cell lymphoproliferative disease may cause serious organ involvement.
Burkitt Lymphoma
EBV is associated with certain forms of Burkitt lymphoma.
Hodgkin Lymphoma
A subset of Hodgkin lymphoma is associated with EBV.
Non-Hodgkin Lymphoma
Selected lymphomas are associated with EBV, particularly in immunocompromised populations.
Nasopharyngeal Carcinoma
EBV is strongly associated with certain nasopharyngeal carcinomas.
Other EBV-Associated Malignancies
Additional rare lymphoid or epithelial malignancies may be linked to EBV.
Primary Immunodeficiency Unmasked by EBV
Unusually severe infection may reveal an underlying immune disorder.
Fulminant EBV Disease
Children with certain inherited immune defects may develop rapidly progressive severe infection.
Transplant Graft Dysfunction
EBV-associated lymphoproliferative disease or treatment adjustments may affect graft function.
Treatment-Related Immunosuppression
Therapy for severe EBV-associated immune or lymphoproliferative disorders may increase infection risk.
Recurrent Opportunistic Infection
Immunocompromised patients may develop additional infections.
Prolonged Hospitalization
Severe complications may require extended inpatient care.
Intensive Care Admission
Airway obstruction, shock, HLH, or organ failure may require critical care.
Reduced Quality of Life
Prolonged fatigue, serious complications, or treatment burden may interfere with normal physical and social functioning.
Death
Rarely, splenic hemorrhage, severe airway obstruction, HLH, fulminant organ failure, or EBV-associated lymphoproliferative disease may result in death.